文献
J-GLOBAL ID:201802273241081645
整理番号:18A1049118
内分泌療法抵抗性乳癌での再発性高反応性ESR1融合蛋白質
Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer
著者 (52件):
HARTMAIER R. J.
(Foundation Medicine Inc., Cambridge)
,
HARTMAIER R. J.
(Univ. Pittsburgh, Pittsburgh)
,
HARTMAIER R. J.
(Magee-Women’s Res. Inst., Pittsburgh)
,
TRABUCCO S. E.
(Foundation Medicine Inc., Cambridge)
,
PRIEDIGKEIT N.
(Univ. Pittsburgh, Pittsburgh)
,
PRIEDIGKEIT N.
(Magee-Women’s Res. Inst., Pittsburgh)
,
CHUNG J. H.
(Foundation Medicine Inc., Cambridge)
,
PARACHONIAK C. A.
(Foundation Medicine Inc., Cambridge)
,
VANDEN BORRE P.
(Foundation Medicine Inc., Cambridge)
,
MORLEY S.
(Foundation Medicine Inc., Cambridge)
,
ROSENZWEIG M.
(Foundation Medicine Inc., Cambridge)
,
GAY L. M.
(Foundation Medicine Inc., Cambridge)
,
GOLDBERG M. E.
(Foundation Medicine Inc., Cambridge)
,
SUH J.
(Foundation Medicine Inc., Cambridge)
,
ALI S. M.
(Foundation Medicine Inc., Cambridge)
,
ROSS J.
(Foundation Medicine Inc., Cambridge)
,
LEYLAND-JONES B.
(Avera Cancer Inst., Sioux Falls)
,
YOUNG B.
(Avera Cancer Inst., Sioux Falls)
,
WILLIAMS C.
(Avera Cancer Inst., Sioux Falls)
,
PARK B.
(Johns Hopkins, Baltimore)
,
TSAI M.
(Minnesota Oncology, Minneapolis)
,
HALEY B.
(UT Southwestern Medical Center, Dallas)
,
PEGUERO J.
(Oncology Consultants Res. Dep., Houston)
,
CALLAHAN R. D.
(UCLA Medical Center, Santa Monica)
,
SACHELARIE I.
(Carlisle Regional Medical Center, Carlisle)
,
CHO J.
(New Bern Cancer Care, New Bern)
,
ATKINSON J. M.
(Magee-Women’s Res. Inst., Pittsburgh)
,
BAHREINI A.
(Magee-Women’s Res. Inst., Pittsburgh)
,
BAHREINI A.
(Univ. Pittsburgh, Pittsburgh, USA)
,
BAHREINI A.
(Isfahan Univ. Medical Sci., Isfahan, IRN)
,
NAGLE A. M.
(Univ. Pittsburgh, Pittsburgh)
,
NAGLE A. M.
(Magee-Women’s Res. Inst., Pittsburgh)
,
PUHALLA S. L.
(Magee-Women’s Res. Inst., Pittsburgh)
,
PUHALLA S. L.
(Univ. Pittsburgh, Pittsburgh, USA)
,
WATTERS R. J.
(Univ. Pittsburgh, Pittsburgh)
,
WATTERS R. J.
(Magee-Women’s Res. Inst., Pittsburgh)
,
WATTERS R. J.
(Univ. Pittsburgh, Pittsburgh, USA)
,
ERDOGAN-YILDIRIM Z.
(Magee-Women’s Res. Inst., Pittsburgh)
,
ERDOGAN-YILDIRIM Z.
(Univ. Pittsburgh, Pittsburgh, USA)
,
CAO L.
(Magee-Women’s Res. Inst., Pittsburgh)
,
CAO L.
(Central South Univ. Xiangya School of Medicine, CHN)
,
OESTERREICH S.
(Univ. Pittsburgh, Pittsburgh)
,
OESTERREICH S.
(Magee-Women’s Res. Inst., Pittsburgh)
,
MATHEW A.
(Univ. Pittsburgh, Pittsburgh, USA)
,
LUCAS P. C.
(Univ. Pittsburgh, Pittsburgh, USA)
,
DAVIDSON N. E.
(Univ. Pittsburgh, Pittsburgh, USA)
,
BRUFSKY A. M.
(Univ. Pittsburgh, Pittsburgh, USA)
,
FRAMPTON G. M.
(Foundation Medicine Inc., Cambridge)
,
STEPHENS P. J.
(Foundation Medicine Inc., Cambridge)
,
CHMIELECKI J.
(Foundation Medicine Inc., Cambridge)
,
LEE A. V.
(Univ. Pittsburgh, Pittsburgh)
,
LEE A. V.
(Magee-Women’s Res. Inst., Pittsburgh)
資料名:
Annals of Oncology
(Annals of Oncology)
巻:
29
号:
4
ページ:
872-880
発行年:
2018年04月
JST資料番号:
W0107A
ISSN:
0923-7534
CODEN:
ANONE2
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)